Humoral autoimmune response to IGF2 mRNA-Binding protein (IMP2/p62) and its tissue-specific expression in colon cancer

Scandinavian Journal of Immunology

Volumn 77, Issue 4, 2013, Pages 255-260

  Liu, W ^a   Li, Z ^a   Xu, W ^a   Wang, Q ^a   Yang, S ^b  

^a Dalian Municipal Central Hospital   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; PROTEIN P62; RNA BINDING PROTEIN; SOMATOMEDIN B; TUMOR ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNITY; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA-BINDING PROTEINS;

EID: 84875598268     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12032     Document Type: Article

References (21)

1. Tan EM. Autoantibodies in pathology and cell biology. Cell 1991;67:841-2.
2. Houghton AN. Cancer antigens: immune recognition of self and altered self. J Exp Med 1994;180:1-4.
3. Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001;108:1411-5.
4. Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 2008;222:328-40.
5. Zhang JY, Chan EKL, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999;189:1101-10.
6. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-70.
7. Mueller-Pillasch F, Lacher U, Wallrap C et al. Cloning of a gene highly expressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997;14:2729-33.
8. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
9. Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 2005;11:4685-8.
10. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012;104:815-40.
11. Zhang JY, Chan EKL, Lu M, Wang X, Peng XX, Tan EM. Autoimmune responses to two cancer-related RRM-KH family proteins p62 and Koc in diverse malignancies. Clin Immunol 2001;100:149-56.
12. Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EKL, Tan EM. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev 2003;12:136-43.
13. Liu W, Wang P, Li Z et al. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Scand J Immunol 2009;69:57-63.
14. Lu M, Nakamura RM, Dent ED et al. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol 2001;159:945-53.
15. Takasaki Y, Fishwild D, Tan EM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984;159:981-92.
16. Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen(cyclin) in DNA replication in living cells. Mol Cell Biol 1989;9:57-66.
17. Cellis JE, Cellis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cell: subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-6.
18. Shpitz B, Bomstein Y, Mekori Y et al. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 1997;174:425-30.
19. Zhang JY, Chan EKL. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma. Autoimmun Rev 2002;1:146-53.
20. Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang JY. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev 2011;10:331-5.
21. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.